Polydatin prevents hypertrophy in phenylephrine induced neonatal mouse cardiomyocytes and pressure-overload mouse models

European Journal of Pharmacology

Volumn 746, Issue , 2014, Pages 186-197

  Dong, Ming ^a   Ding, Wenwen ^b   Liao, Yansong ^c   Liu, Ye ^d   Yan, Dewen ^e   Zhang, Yi ^a   Wang, Rongming ^a   Zheng, Na ^a   Liu, Shuaiye ^a   Liu, Jie ^a  

^a SHENZHEN UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d HEBEI MEDICAL UNIVERSITY   (China)

^e THE FIRST AFFILIATED HOSPITAL OF SHENZHEN UNIVERSITY   (China)

Author keywords

Hypertrophy; Polydatin; Reactive oxygen species; Rho activity

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; ATRIAL NATRIURETIC FACTOR; ATRIAL NATRIURETIC PEPTIDE, RAT; CARDIOTONIC AGENT; GLUCOSIDE; HERBACEOUS AGENT; PHENYLEPHRINE; PICEID; RHO KINASE; STILBENE DERIVATIVE;

ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CARDIOMEGALY; CELL CULTURE; CELL SIZE; CHEMISTRY; CYTOLOGY; DISEASE MODEL; DRUG EFFECTS; HEART FAILURE; HEART VENTRICLE; HEART VENTRICLE REMODELING; MALE; METABOLISM; NEWBORN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; RAT;

ADRENERGIC ALPHA-1 RECEPTOR AGONISTS; ANIMALS; ANIMALS, NEWBORN; ATRIAL NATRIURETIC FACTOR; CARDIOMEGALY; CARDIOTONIC AGENTS; CELL SIZE; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; GLUCOSIDES; HEART FAILURE; HEART VENTRICLES; MALE; MICE, INBRED C57BL; OXIDATIVE STRESS; PHENYLEPHRINE; RATS; RHO-ASSOCIATED KINASES; STILBENES; VENTRICULAR REMODELING;

EID: 84914098532     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2014.11.012     Document Type: Article

References (33)

1. R. Aikawa, I. Komuro, R. Nagai, and Y. Yazaki Rho plays an important role in angiotensin II-induced hypertrophic responses in cardiac myocytes Mol. Cell. Biochem. 212 2000 177 182
2. J.H. Brown, D.P. Del Re, and M.A. Sussman The Rac and Rho hall of fame: a decade of hypertrophic signaling hits Circ. Res. 98 2006 730 742
3. P.W. Burridge, E. Matsa, P. Shukla, Z.C. Lin, J.M. Churko, A.D. Ebert, F. Lan, S. Diecke, B. Huber, N.M. Mordwinkin, J.R. Plews, O.J. Abilez, B. Cui, J.D. Gold, and J.C. Wu Chemically defined generation of human cardiomyocytes Nat. Methods 11 2014 855 860
4. Y. Cheng, H.T. Zhang, L. Sun, S. Guo, S. Ouyang, Y. Zhang, and J. Xu Involvement of cell adhesion molecules in polydatin protection of brain tissues from ischemia-reperfusion injury Brain Res. 1110 2006 193 200
5. A.Y. Chi, G.B. Waypa, P.T. Mungai, and P.T. Schumacker Prolonged hypoxia increases ROS signaling and RhoA activation in pulmonary artery smooth muscle and endothelial cells Antioxid. Redox Signal. 12 2010 603 610
6. 2+handling, excitation-contraction coupling and beta-adrenergic signaling in rat ventricular myocytes J. Mol. Cell. Cardiol. 53 2012 646 656
7. M. Dong, J.K. Liao, F. Fang, A.P. Lee, B.P. Yan, M. Liu, and C.M. Yu Increased Rho kinase activity in congestive heart failure Eur. J. Heart Fail. 14 2012 965 973
8. J.P. Gao, C.X. Chen, W.L. Gu, Q. Wu, Y. Wang, and J. Lu Effects of polydatin on attenuating ventricular remodeling in isoproterenol-induced mouse and pressure-overload rat models Fitoterapia 81 2010 953 960
9. S.A. Hamid, H.S. Bower, and G.F. Baxter Rho kinase activation plays a major role as a mediator of irreversible injury in reperfused myocardium Am. J. Physiol. Heart Circ. Physiol. 292 2007 H2598 H2606
10. J.C. Hunter, A. Zeidan, S. Javadov, A. Kilic, V. Rajapurohitam, and M. Karmazyn Nitric oxide inhibits endothelin-1-induced neonatal cardiomyocyte hypertrophy via a RhoA-ROCK-dependent pathway J. Mol. Cell. Cardiol. 47 2009 810 818
11. 2+ sensitization in pulmonary vascular smooth muscle following chronic hypoxia Am. J. Physiol. Lung Cell. Mol. Physiol. 295 2008 L515 L529
12. 2+ leak by reducing oxidative modification of ryanodine receptors Free Radic. Biol. Med. 60 2013 292 299
13. 2+sensitization Free Radic. Biol. Med. 46 2009 633 642
14. K. Kuwahara, G.C. Teg Pipes, J. McAnally, J.A. Richardson, J.A. Hill, R. Bassel-Duby, and E.N. Olson Modulation of adverse cardiac remodeling by STARS, a mediator of MEF2 signaling and SRF activity J. Clin. Investig. 117 2007 1324 1334
15. R.M. Lang, M. Bierig, R.B. Devereux, F.A. Flachskampf, E. Foster, P.A. Pellikka, M.H. Picard, M.J. Roman, J. Seward, J.S. Shanewise, S.D. Solomon, K.T. Spencer, M.S. Sutton, W.J. Stewart Chamber Quantification Writing Group American Society of Echocardiography's Guidelines Standards Committee European Association of, Echocardiography Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J. Am. Soc. Echocardiogr. 18 2005 1440 1463
16. D. Levy, R.J. Garrison, D.D. Savage, W.B. Kannel, and W.P. Castelli Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study N. Engl. J. Med. 322 1990 1561 1566
17. Y.H. Liao, N. Xia, S.F. Zhou, T.T. Tang, X.X. Yan, B.J. Lv, S.F. Nie, J. Wang, Y. Iwakura, H. Xiao, J. Yuan, H. Jevallee, F. Wei, G.P. Shi, and X. Cheng Interleukin-17A contributes to myocardial ischemia/reperfusion injury by regulating cardiomyocyte apoptosis and neutrophil infiltration J. Am. Coll. Cardiol. 59 2012 420 429
18. P.Y. Liu, J.H. Chen, L.J. Lin, and J.K. Liao Increased Rho kinase activity in a Taiwanese population with metabolic syndrome J. Am. Coll. Cardiol. 49 2007 1619 1624
19. J. Pan, U.S. Singh, T. Takahashi, Y. Oka, A. Palm-Leis, B.S. Herbelin, and K.M. Baker PKC mediates cyclic stretch-induced cardiac hypertrophy through Rho family GTPases and mitogen-activated protein kinases in cardiomyocytes J. Cell. Physiol. 202 2005 536 553
20. A. Phrommintikul, L. Tran, A. Kompa, B. Wang, A. Adrahtas, D. Cantwell, D.J. Kelly, and H. Krum Effects of a Rho kinase inhibitor on pressure overload induced cardiac hypertrophy and associated diastolic dysfunction Am. J. Physiol. Heart Circ. Physiol. 294 2008 H1804 H1814
21. V.P. Sah, M. Hoshijima, K.R. Chien, and J.H. Brown Rho is required for Galphaq and alpha1-adrenergic receptor signaling in cardiomyocytes. Dissociation of Ras and Rho pathways J. Biol. Chem. 271 1996 31185 31190
22. M. Sano, T. Minamino, H. Toko, H. Miyauchi, M. Orimo, Y. Qin, H. Akazawa, K. Tateno, Y. Kayama, M. Harada, I. Shimizu, T. Asahara, H. Hamada, S. Tomita, J.D. Molkentin, Y. Zou, and I. Komuro p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload Nature 446 2007 444 448
23. D.B. Sawyer, D.A. Siwik, L. Xiao, D.R. Pimentel, K. Singh, and W.S. Colucci Role of oxidative stress in myocardial hypertrophy and failure J. Mol. Cell. Cardiol. 34 2002 379 388
24. S.Y. Su, and C.L. Hsieh Anti-inflammatory effects of Chinese medicinal herbs on cerebral ischemia Chin. Med. 6 2011 26
25. X. Wang, R. Song, H.N. Bian, U.T. Brunk, M. Zhao, and K.S. Zhao Polydatin, a natural polyphenol, protects arterial smooth muscle cells against mitochondrial dysfunction and lysosomal destabilization following hemorrhagic shock Am. J. Physiol. Regul. Integr. Comp. Physiol. 302 2012 R805 R814
26. X. Wang, R. Song, Y. Chen, M. Zhao, and K.S. Zhao Polydatin - a new mitochondria protector for acute severe hemorrhagic shock treatment Expert Opin. Investig. Drugs 22 2013 169 179
27. A. Zeidan, S. Javadov, S. Chakrabarti, and M. Karmazyn Leptin-induced cardiomyocyte hypertrophy involves selective caveolae and RhoA/ROCK-dependent p38 MAPK translocation to nuclei Cardiovasc. Res. 77 2008 64 72
28. A. Zeidan, S. Javadov, and M. Karmazyn Essential role of Rho/ROCK-dependent processes and actin dynamics in mediating leptin-induced hypertrophy in rat neonatal ventricular myocytes Cardiovasc. Res. 72 2006 101 111
29. H. Zhang, C.H. Yu, Y.P. Jiang, C. Peng, K. He, J.Y. Tang, and H.L. Xin Protective effects of polydatin from Polygonum cuspidatum against carbon tetrachloride-induced liver injury in mice PLoS One 7 2012 e46574
30. L.P. Zhang, H.J. Ma, H.M. Bu, M.L. Wang, Q. Li, Z. Qi, and Y. Zhang Polydatin attenuates ischemia/reperfusion-induced apoptosis in myocardium of the rat Sheng Li Xue Bao 61 2009 367 372
31. L.P. Zhang, C.Y. Yang, Y.P. Wang, F. Cui, and Y. Zhang Protective effect of polydatin against ischemia/reperfusion injury in rat heart Sheng Li Xue Bao 60 2008 161 168
32. K.S. Zhao Hemorheologic events in severe shock Biorheology 42 2005 463 477
33. K.S. Zhao, C. Jin, X. Huang, J. Liu, W.S. Yan, Q. Huang, and W. Kan The mechanism of polydatin in shock treatment Clin. Hemorheol. Microcirc. 29 2003 211 217